ESOR Special Focus Series

Lung Cancer Screening Episode 1

  • Lung Cancer Screening
  • 6 Lectures
  • 330 Minutes
  • 6 Speakers

Lectures

1
Lung cancer screening trials: acquired evidence and remaining questions

Lung cancer screening trials: acquired evidence and remaining questions

40:00Cornelia Schaefer-Prokop, Amersfoort / NL

2
Epidemiology of lung cancer in European countries: what are the trends

Epidemiology of lung cancer in European countries: what are the trends

40:00Hana Zahed, Lyon / FR

3
How to conduct lung cancer screening: technical requirements and quality assurance

How to conduct lung cancer screening: technical requirements and quality assurance

40:01Marie-Pierre Revel, Paris / FR

4
Solid nodules: morphological evaluation,  criteria for growth during follow-up

Solid nodules: morphological evaluation, criteria for growth during follow-up

40:00Helmut Prosch, Vienna / AT

5
Subsolid nodules: morphological evaluation,  criteria for growth during follow-up

Subsolid nodules: morphological evaluation, criteria for growth during follow-up

40:00Mario Silva, Parma / IT

6
Case-based session 1

Case-based session 1

40:01Jens Vogel-Claussen, Hannover / DE

Description

COURSE INFORMATION

The Special Focus Series offers unique courses, tailored to address some of the most pressing topics for radiologists today. The series includes both online and onsite courses, in a range of different formats. From oncology and mental health to teaching skills and sustainability practices, the Special Focus Series aims to give you the skills modern radiologists need.

Day one of the Lung Cancer Screening course will cover everything from trends, technical requirements and test trials to the details of solid and subsolid nodules, as well as concrete cases from cancer screening programmes.

Attention: You need to attend both days to receive a CME certificate!
See here for more information.

 

LEARNING OBJECTIVES

  • learn about the scientific evidence obtained from lung cancer screening trials
  • gain knowledge of the epidemiology of lung cancer across different European countries
  • develop skills in dose requirements and reading modalities
  • gain confidence in the assessment of solid nodules
  • learn to describe and manage sub-solid nodules effectively

 

PROGRAMME ONLINE

Monday, January 20, 2025

12:30 – 13:10

Lung cancer screening trials: acquired evidence and remaining questions

Cornelia Schaefer-Prokop, Amersfoort/NL

13:10 – 13:50

Epidemiology of lung cancer in European countries: what are the trends

H. Zahed, Lyon/FR

13:50 – 14:30

How to conduct lung cancer screening: technical requirements and quality assurance

Marie-Pierre Revel Paris/FR

14:30 – 15:00

Q&A

15:00 – 15:30

Break

15:30 – 16:10

Solid nodules: morphological evaluation,  criteria for growth during follow-up

Helmut Prosch, Vienna/AT

16:10 – 16:50

Subsolid nodules: morphological evaluation,  criteria for growth during follow-up

Mario Silva, Parma/IT

16:50 – 17:30

Case-Based Session

Jens Vogel-Claussen, Hannover/DE

17:30 – 18:00

Q&A Session

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.

Tags

Moderators

  • Marie-Pierre Revel

    Paris / France

Speakers

  • Cornelia M. Schaefer-Prokop

    Amersfoort / Netherlands
  • Marie-Pierre Revel

    Paris / France
  • Helmut Prosch

    Vienna / Austria
  • Mario Silva

    Parma / Italy
  • Jens Vogel-Claussen

    Hannover / Germany